Advertisement

Topics

Biosimilar pegfilgrastim highly similar to Neulasta

05:36 EDT 18 Aug 2017 | Generics and Biosimilars Initiative

Canada-based Apobiologix published analytical results demonstrating the similarity of their pegfilgrastim product to the US reference product, Amgen’s Neulasta (pegfilgrastim) [1].

Original Article: Biosimilar pegfilgrastim highly similar to Neulasta

NEXT ARTICLE

More From BioPortfolio on "Biosimilar pegfilgrastim highly similar to Neulasta"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...